rs1554032216
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_000046.5(ARSB):c.160G>C(p.Asp54His) variant causes a missense change. The variant allele was found at a frequency of 0.000000726 in 1,377,616 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_000046.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARSB | NM_000046.5 | c.160G>C | p.Asp54His | missense_variant | Exon 1 of 8 | ENST00000264914.10 | NP_000037.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARSB | ENST00000264914.10 | c.160G>C | p.Asp54His | missense_variant | Exon 1 of 8 | 1 | NM_000046.5 | ENSP00000264914.4 | ||
ARSB | ENST00000396151.7 | c.160G>C | p.Asp54His | missense_variant | Exon 2 of 8 | 1 | ENSP00000379455.3 | |||
ARSB | ENST00000565165.2 | c.160G>C | p.Asp54His | missense_variant | Exon 1 of 5 | 1 | ENSP00000456339.2 | |||
ARSB | ENST00000521117.1 | c.*23G>C | downstream_gene_variant | 3 | ENSP00000428611.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 7.26e-7 AC: 1AN: 1377616Hom.: 0 Cov.: 31 AF XY: 0.00000146 AC XY: 1AN XY: 682874
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Variant summary: ARSB c.160G>C (p.Asp54His) results in a non-conservative amino acid change located in the sulfatase N terminal domain (IPR000917) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 175716 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.160G>C in individuals affected with Mucopolysaccharidosis Type VI (Maroteaux-Lamy Syndrome) and no experimental evidence demonstrating its impact on protein function have been reported. Other variants affecting the same codon have been classified pathogenic or likely pathogenic in ClinVar (CV IDs 1471409, 559730). No submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as uncertain significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.